252 related articles for article (PubMed ID: 31245977)
1. Evaluation of Maculopathy in Patients Using Hydroxychloroquine.
Uğurlu A; Aslanova M; Cebeci Z; Kır Mercül N
Turk J Ophthalmol; 2019 Jun; 49(3):149-153. PubMed ID: 31245977
[TBL] [Abstract][Full Text] [Related]
2. Macular sensitivities measured by microperimetry in patients on hydroxychloroquine treatment.
Eren M; Kucukevcilioglu M; Durukan AH
Cutan Ocul Toxicol; 2018 Sep; 37(3):275-280. PubMed ID: 29495877
[TBL] [Abstract][Full Text] [Related]
3. Fundus autofluorescence and spectral domain optical coherence tomography in early detection of Plaquenil maculopathy.
Kelmenson AT; Brar VS; Murthy RK; Chalam KV
Eur J Ophthalmol; 2010; 20(4):785-8. PubMed ID: 20099229
[TBL] [Abstract][Full Text] [Related]
4. Progression of hydroxychloroquine toxic effects after drug therapy cessation: new evidence from multimodal imaging.
Mititelu M; Wong BJ; Brenner M; Bryar PJ; Jampol LM; Fawzi AA
JAMA Ophthalmol; 2013 Sep; 131(9):1187-97. PubMed ID: 23887202
[TBL] [Abstract][Full Text] [Related]
5. LONGITUDINAL CHANGES IN EYES WITH HYDROXYCHLOROQUINE RETINAL TOXICITY.
Allahdina AM; Chen KG; Alvarez JA; Wong WT; Chew EY; Cukras CA
Retina; 2019 Mar; 39(3):473-484. PubMed ID: 30741731
[TBL] [Abstract][Full Text] [Related]
6. Swept source optical coherence tomography angiography in patients treated with hydroxychloroquine: correlation with morphological and functional tests.
Forte R; Haulani H; Dyrda A; Jürgens I
Br J Ophthalmol; 2021 Sep; 105(9):1297-1301. PubMed ID: 30842084
[TBL] [Abstract][Full Text] [Related]
7. Microperimetric sensitivity in patients on hydroxychloroquine (Plaquenil) therapy.
Jivrajka RV; Genead MA; McAnany JJ; Chow CC; Mieler WF
Eye (Lond); 2013 Sep; 27(9):1044-52. PubMed ID: 23764990
[TBL] [Abstract][Full Text] [Related]
8. A possible early sign of hydroxychloroquine macular toxicity.
Brandao LM; Palmowski-Wolfe AM
Doc Ophthalmol; 2016 Feb; 132(1):75-81. PubMed ID: 26792426
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of spectral-domain optical coherence tomography features in assessment of visual prognosis in eyes with acute welding arc maculopathy.
Zhang C; Dang G; Zhao T; Wang D; Su Y; Qu Y
Int Ophthalmol; 2019 May; 39(5):1081-1088. PubMed ID: 29651692
[TBL] [Abstract][Full Text] [Related]
10. Subjective and objective screening tests for hydroxychloroquine toxicity.
Cukras C; Huynh N; Vitale S; Wong WT; Ferris FL; Sieving PA
Ophthalmology; 2015 Feb; 122(2):356-66. PubMed ID: 25444344
[TBL] [Abstract][Full Text] [Related]
11. Macular retinal ganglion cell-inner plexiform layer thickness in patients on hydroxychloroquine therapy.
Lee MG; Kim SJ; Ham DI; Kang SW; Kee C; Lee J; Cha HS; Koh EM
Invest Ophthalmol Vis Sci; 2014 Nov; 56(1):396-402. PubMed ID: 25425304
[TBL] [Abstract][Full Text] [Related]
12. Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy.
Michaelides M; Stover NB; Francis PJ; Weleber RG
Arch Ophthalmol; 2011 Jan; 129(1):30-9. PubMed ID: 21220626
[TBL] [Abstract][Full Text] [Related]
13. Macular toxicity after short-term hydroxychloroquine therapy.
Pasaoglu I; Onmez FE
Indian J Ophthalmol; 2019 Feb; 67(2):289-292. PubMed ID: 30672499
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a follow-up protocol for patients on chloroquine and hydroxychloroquine treatment.
Sanabria MR; Toledo-Lucho SC
Arch Soc Esp Oftalmol; 2016 Jan; 91(1):10-4. PubMed ID: 26627497
[TBL] [Abstract][Full Text] [Related]
15. Case Report: Hydroxychloroquine Retinopathy.
Eldeeb M; Chan EW; Omar A
Optom Vis Sci; 2018 Jun; 95(6):545-549. PubMed ID: 29787487
[TBL] [Abstract][Full Text] [Related]
16. Diabetic macular edema: fundus autofluorescence and functional correlations.
Vujosevic S; Casciano M; Pilotto E; Boccassini B; Varano M; Midena E
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):442-8. PubMed ID: 20720226
[TBL] [Abstract][Full Text] [Related]
17. Rapid Onset of Retinal Toxicity From High-Dose Hydroxychloroquine Given for Cancer Therapy.
Leung LS; Neal JW; Wakelee HA; Sequist LV; Marmor MF
Am J Ophthalmol; 2015 Oct; 160(4):799-805.e1. PubMed ID: 26189086
[TBL] [Abstract][Full Text] [Related]
18. Disparity between visual fields and optical coherence tomography in hydroxychloroquine retinopathy.
Marmor MF; Melles RB
Ophthalmology; 2014 Jun; 121(6):1257-62. PubMed ID: 24439759
[TBL] [Abstract][Full Text] [Related]
19. Structural and Functional Characterization of the Retinal Effects of Hydroxychloroquine Treatment in Healthy Eyes.
Gil P; Nunes A; Farinha C; Teixeira D; Pires I; Silva R
Ophthalmologica; 2019; 241(4):226-233. PubMed ID: 30654376
[TBL] [Abstract][Full Text] [Related]
20. [Clinical evaluation of the new screening procedures for hydroxychloroquine retinopathy, according to the American Academy of Ophthalmology guidelines. Prospective study of 184 patients].
Jaumouillé S; Espargillière D; Mouriaux F; Mortemousque B
J Fr Ophtalmol; 2015 May; 38(5):377-87. PubMed ID: 25913441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
